AbbVie Inc. Press Releases

AbbVie Initiates Phase 3 Study of Its Investigational Compound Atrasentan on Renal Outcomes in Patients with Diabetic Nephropathy
05/20/2013 10:45AM - PR Newswire

AbbVie and Galapagos Extend GLPG0634 Collaboration to Include Crohn's Disease
05/17/2013 1:15AM - PR Newswire

AbbVie to Present Data on Investigational Anti-Cancer Compounds at American Society of Clinical Oncology Annual Meeting
05/15/2013 6:21PM - PR Newswire

AbbVie and Alvine to Collaborate on Investigational Oral Therapy for Celiac Disease
05/14/2013 9:15AM - PR Newswire

AbbVie to Present at Bank of America Merrill Lynch 2013 Health Care Conference
05/07/2013 9:00AM - PR Newswire

AbbVie's Investigational HCV Regimen Receives Breakthrough Therapy Designation from the U.S. Food and Drug Administration
05/06/2013 9:00AM - PR Newswire

AbbVie CF Scholarship Application Now Available for Exceptional Undergraduate and Graduate Students with Cystic Fibrosis
05/01/2013 11:00AM - PR Newswire

AbbVie Reports First-Quarter 2013 Financial Results
04/26/2013 7:51AM - PR Newswire

New Data from AbbVie's Phase IIb Aviator Trial Demonstrate High Sustained Viral Response Rates Across Multiple Patient Types with HCV Genotype 1
04/23/2013 6:18AM - PR Newswire

Sofia Vergara Encourages Individuals with Hypothyroidism to "Follow the Script"
04/17/2013 12:12PM - PR Newswire

AbbVie to Host First-Quarter Earnings Conference Call
04/08/2013 9:00AM - PR Newswire

Actavis Confirms Generic AndroGel® 1.62% Patent Challenge
04/01/2013 8:00AM - PR Newswire

Receptos Licenses Anti-Interleukin-13 Antibody from AbbVie for Phase 2 Development in Orphan Disease
03/13/2013 8:00AM - PR Newswire

Aggressive R&D Initiatives and Innovative Pipelines - Research Report on J&J, Merck, AbbVie, Novartis, and GSK
03/07/2013 8:00AM - PR Newswire

AbbVie to Present at Barclays Global Health Care Conference
02/27/2013 9:15AM - PR Newswire